SUPPLEMENT

H1 FY2025 — Additional analyst information

H1 FY2025PDF · 18 pages894 KB
This pack has been prepared to aid discussion and provide further
supplementary information only and has not been subject to an
external review or audit

-- 1 of 18 --

CUSTOMERS PER ENTITY
Life Policyholders
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	450 866 	449 211 	449 300 	447 690 	449 130 	449 020 	449 378 	448 313 	445 813 	446 713 	452 561 	446 475
Invest
Invest - DRO 	137 441 	137 503 	137 718 	137 189 	135 819 	134 721 	133 741 	132 817 	131 244 	129 606 	127 831 	124 135
Invest - Other 	236 055 	229 871 	225 414 	221 273 	216 479 	212 161 	206 778 	201 210 	195 231 	192 615 	189 210 	185 025
Group (lives) 	707 154 	711 051 	707 756 	711 161 	680 754 	584 081 	562 769 	576 450 	562 440 	578 035 	551 219 	544 443
Group schemes 	2 581 	2 616 	2 647 	2 663 	2 666 	2 793 	2 844 	2 827 	2 825 	2 797 	2 740 	2 771
Life NB APE
6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to 	6 months to 	12 months to
R million 	December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	1 440 	2 778 	1 444 	2 663 	1 355 	2 362 	1 204 	2 072 	1 068 	2 126 	1 165 	2 215
Group 	23 	164 	75 	175 	130 	181 	64 	193 	94 	160 	75 	97
Invest - Recurring 	867 	1 673 	851 	1 551 	796 	1 428 	737 	1 167 	573 	1 164 	686 	1 221
Invest - Single APE1 	867 	1 627 	778 	1 500 	708 	1 493 	782 	1 570 	744 	1 508 	671 	1 382
Total Life APE 	3 197 	6 242 	3 148 	5 889 	2 989 	5 463 	2 786 	5 001 	2 478 	4 958 	2 597 	4 915
1 APE shown at 10% of Single premium
Health Members
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
DHMS - Keycare 	204 847 	207 934 	226 848 	225 517 	232 988 	232 055 	234 421 	235 841 	230 960 	232 714 	243 046 	240 140
DHMS - Non-Keycare 	1 154 532 	1 152 395 	1 147 016 	1 149 861 	1 142 556 	1 135 853 	1 118 591 	1 111 545 	1 099 553 	1 111 079 	1 108 674 	1 110 401
In-House Schemes 	356 504 	354 944 	321 333 	319 813 	321 838 	318 246 	316 973 	321 613 	321 767 	319 974 	317 408 	316 410
Total 	1 715 883 	1 715 273 	1 695 197 	1 695 191 	1 697 382 	1 686 154 	1 669 985 	1 668 999 	1 652 280 	1 663 767 	1 669 128 	1 666 951
Health Lives
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
DHMS - Keycare 	343 648 	350 038 	385 906 	384 759 	398 397 	397 595 	401 307 	404 984 	400 108 	403 392 	420 869 	415 436
DHMS - Non-Keycare 	2 391 556 	2 394 452 	2 402 336 	2 413 851 	2 412 595 	2 406 528 	2 383 486 	2 375 082 	2 358 232 	2 381 735 	2 387 237 	2 394 336
In-House Schemes 	800 093 	798 933 	710 485 	707 406 	710 427 	704 472 	699 342 	707 293 	704 749 	698 534 	689 688 	686 114
Total 	3 535 297 	3 543 423 	3 498 727 	3 506 016 	3 521 419 	3 508 595 	3 484 135 	3 487 359 	3 463 089 	3 483 661 	3 497 794 	3 495 886
Vitality SA
December 2024 	June 2024 	December 2023 	June 2023 December 20222 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Total Vitality Health,
Vitality Drive and Vitality
Money programme lives
3 038 785 	2 922 347 	2 822 972 	2 652 877 	2 498 048 	2 348 834 	2 242 401 	2 163 411 	2 122 453 	2 065 868 	2 060 011 	1 987 237
2 restated to include for LA wellness figures
VitalityHealth Members
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	141 014 	140 400 	138 278 	135 117 	129 568 	124 395 	117 007 	113 189 	108 955 	105 915 	104 997 	101 702
SME 	344 320 	340 983 	327 876 	310 624 	285 865 	263 216 	238 540 	222 961 	211 949 	212 305 	209 509 	201 960
Corporate 	128 241 	120 685 	112 941 	108 191 	102 823 	99 578 	89 881 	86 149 	80 514 	81 124 	78 050 	70 583
Trust and Cost Plus 	20 198 	20 237 	16 448 	16 339 	14 511 	8 698 	3 944 	2 731 	2 639 	- 	- 	-
Total 	633 773 	622 305 	595 543 	570 271 	532 767 	495 887 	449 372 	425 030 	404 057 	399 344 	392 556 	374 245
VitalityHealth Lives
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Individual 	261 481 	260 210 	256 527 	250 551 	238 629 	227 684 	212 896 	204 890 	195 996 	188 976 	186 559 	179 811
SME 	545 424 	541 111 	522 753 	496 299 	460 442 	429 110 	395 777 	374 179 	357 768 	356 907 	353 763 	342 431
Corporate 	202 151 	191 015 	178 163 	171 364 	163 120 	158 890 	148 654 	143 905 	135 218 	135 440 	131 991 	120 157
Trust and Cost Plus 	35 214 	35 163 	27 349 	26 854 	22 673 	15 903 	6 509 	4 066 	3 956 	- 	- 	-
Total 	1 044 270 	1 027 499 	984 792 	945 068 	884 864 	831 587 	763 836 	727 040 	692 938 	681 323 	672 313 	642 399
VitalityLife Policies
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Policies 	782 296 	679 382 	646 564 	622 451 	593 322 	565 778 	535 281 	517 913 	493 970 	474 890 	458 675 	434 678
VitalityLife Lives
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Lives3 	852 154 	810 050 	782 296 	764 699 	735 137 	702 105 	669 139 	647 020 	617 051 	594 799 	577 965 	549 526
3 restated to include unique lives only
Discovery Insure Policies
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Policies 	213 762 	214 297 	215 297 	211 223 	214 315 	213 453 	212 570 	202 335 	191 936 	178 517 	169 920 	159 171
Discovery Bank
December 2024 	June 2024 	December 2023 	June 2023 December 2022 	June 2022 December 2021 	June 2021 December 2020 	June 2020 December 2019 	June 2019
Primary Clients 	1 092 386 	958 055 	825 069 	702,131 	581 457 	470 220 	385 177 	331 088 	287 183 	206 810 	61 731 	1 476
Total Accounts 	2 608 023 	2 271 703 	1 933 839 	1,625,912 	1 312 970 	1 023 790 	793 215 	648 546 	521 081 	357 416 	141 660 	3 740
2 Membership

-- 2 of 18 --

VALUE OF NEW BUSINESS AT POINT OF SALE VS VALUATION DATE
December 2024
VNB at Point of Sale
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Acquisition Costs and Initial strain 	(264) 	(1 446) 	(808) 	(1 685) 	(4 203)
Value of In Force 	757 	1 721 	1 015 	1 788 	5 281
Cost of Capital 	(21) 	(36) 	(26) 	(42) 	(125)
472 	239 	181 	61 	953
New business contribution to value of in force at valuation date
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Value of In Force 	755 	1 277 	982 	1 642 	4 656
Cost of Capital 	(21) 	(36) 	(26) 	(42) 	(125)
734 	1 241 	956 	1 600 	4 531
June 2024
VNB at Point of Sale
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Acquisition Costs and Initial strain 	(550) 	(2 833) 	(1 560) 	(1 132) 	(6 075)
Value of In Force 	1 653 	3 393 	2 051 	1 074 	8 171
Cost of Capital 	(52) 	(79) 	(63) 	(70) 	(264)
1 051 	481 	428 	(128) 	1 832
New business contribution to value of in force at valuation date
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Value of In Force 	1 615 	2 454 	1 906 	909 	6 884
Cost of Capital 	(51) 	(79) 	(60) 	(68) 	(258)
1 564 	2 375 	1 846 	841 	6 626
December 2023
VNB at Point of Sale
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Acquisition Costs and Initial strain 	(253) 	(1 452) 	(754) 	(635) 	(3 094)
Value of In Force 	659 	1 739 	999 	535 	3 932
Cost of Capital 	(21) 	(45) 	(53) 	(35) 	(154)
385 	242 	192 	(135) 	684
New business contribution to value of in force at valuation date
R million 	Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Value of In Force 	660 	1 256 	960 	513 	3 389
Cost of Capital 	(21) 	(45) 	(52) 	(28) 	(146)
639 	1 211 	908 	485 	3 243
3 Value of New Business

-- 3 of 18 --

EV RECONCILIATION TO INCOME STATEMENT
for the year ended 31 December 2024
R million
Embedded
Value
Earnings
Value of In-
Force
Cost of
required
Capital
Impact on
Income
Statement
Adjustment to
Shareholders
Funds
Statement of
Changes in
Equity
Total profit from new business (at point of sale) 	953 	4 497 	(125) 	(3 419)
- Health and Vitality 	472 	734 	(21) 	(241) 	- 	-
- Life 	239 	1 241 	(36) 	(966) 	- 	-
- VitalityHealth 	181 	950 	(26) 	(743) 	- 	-
- VitalityLife 	61 	1 572 	(42) 	(1 469) 	- 	-
Profit from existing business
* Expected return 	5 268 	925 	(12) 	4 355
- Health and Vitality 	1 981 	306 	3 	1 672
Expected transfer from VIF to net worth 	- 	(1 672) 	- 	1 672
Unwinding of the risk discount rate 	1 981 	1 978 	3 	-
- Life 	2 265 	1 236 	- 	1 029
Expected transfer from VIF to net worth 	- 	(1 029) 	- 	1 029
Unwinding of the risk discount rate 	2 265 	2 265 	- 	-
- VitalityHealth 	458 	(578) 	(14) 	1 050
Expected transfer from VIF to net worth 	- 	(1 050) 	- 	1 050
Unwinding of the risk discount rate 	458 	472 	(14) 	-
- VitalityLife 	564 	(39) 	(1) 	604
Expected transfer from VIF to net worth 	- 	(604) 	- 	604
Unwinding of the risk discount rate 	564 	565 	(1) 	-
* Change in methodology and assumptions 	1 241 	(764) 	(38) 	2 043
- Health and Vitality 	(97) 	(117) 	20 	-
- Life 	1 487 	1 152 	(51) 	386
- VitalityHealth 	- 	- 	- 	-
- VitalityLife 	(149) 	(1 799) 	(7) 	1 657
* Experience variances 	1 447 	1 181 	80 	186
- Health and Vitality 	22 	(17) 	- 	39
- Life 	468 	436 	- 	32
- VitalityHealth 	816 	807 	81 	(72)
- VitalityLife 	141 	(45) 	(1) 	187
Increase in goodwill and intangibles 	(179) 	- 	- 	- 	(179) 	-
Other initiatives 	1 160 	9 	- 	1 151 	- 	-
Non-recurring expenses 	(103) 	- 	- 	(103) 	- 	-
Acquisition costs 	(11) 	(2) 	- 	(9) 	- 	-
Finance costs 	(1 633) 	- 	- 	(1 633) 	- 	-
Other 	(4) 	(1) 	1 	- 	(4) 	-
Foreign Exchange Rate Movements 	1 125 	701 	(21) 	(299) 	(85) 	829
Intangibles 	(85) 	- 	- 	- 	(85) 	-
Other 	1 210 	701 	(21) 	(299) 	- 	829
Return on shareholders' funds 	799 	- 	- 	755 	- 	44
Unrealised gain on investments and realised gain on investments
transferred to income statement 	630 	- 	- 	586 	- 	44
Health and Vitality investment income 	37 	- 	- 	37 	- 	-
Life investment income 	132 	- 	- 	132 	- 	-
VitalityHealth investment income 	- 	- 	- 	- 	- 	-
VitalityLife investment income 	- 	- 	- 	- 	- 	-
Amortisation of Intangibles 	(30) 	- 	- 	(227) 	197 	-
Amortisation of intangibles from business combinations 	(30) 	- 	- 	(44) 	14 	-
Amortisation of systems intangibles 	- 	- 	- 	(183) 	183 	-
VitalityHealth and VitalityLife DAC and unemployment reserve 	- 	- 	- 	292 	(292) 	-
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 	- 	- 	- 	(54) 	54 	-
Life assets under insurance contracts 	- 	- 	- 	1 906 	(4 117) 	2 211
VitalityLife net assets under insurance contracts 	- 	- 	- 	(418) 	135 	283
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset 	- 	- 	- 	30 	(30) 	-
VitalityHealth FinRe 	- 	- 	- 	292 	(292) 	-
Equity settled share based payment mark-to-market adjustment 	- 	- 	- 	(227) 	227 	-
Embedded value earnings 	10 033 	6 546 	(115) 	4 329 	(4 094) 	3 367
Adjustment to Shareholders' Funds:
Change in: *
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset 	(322)
Intangibles & Goodwill 	(71)
Life net assets under insurance contracts 	(4 117)
VitalityLife net assets under insurance contracts 	135
1 DP IFRS 16 financial lease accounting 	54
Equity settled share based payment mark-to-market adjustment 	227
* The total change in the net assets under insurance contracts consists of the change in the Negative Rand Reserve (NRR), which is zeroised in the embedded value. The change in the NRR is split
between the Income Statement and the change in Other Comprehensive Income (OCI) which flows through the Statement of Changes in Equity (SOCIE).
4 EV recon

-- 4 of 18 --

EV BUILD-UP PER ENTITY
for the year ended 31 December 2024
R million Health and Vitality Life and Invest VitalityHealth VitalityLife 	Other 	Total
Value of in-force business at 30 June 2024 	26 914 	35 813 	13 904 	14 435 	- 	91 066
Expected return (in-force business) 	1 962 	2 228 	448 	533 	- 	5 171
Release of profits (in-force business) 	(1 672) 	(1 029) 	(1 050) 	(604) 	- 	(4 355)
Value of new business 	736 	1 685 	989 	1 746 	- 	5 156
Expected return (new business) 	19 	37 	10 	31 	- 	97
Release of profits (new business) 	(23) 	(480) 	(65) 	(216) 	- 	(784)
Experience variances 	(17) 	436 	888 	(46) 	- 	1 261
Methodology changes 	(97) 	1 101 	- 	(1 806) 	- 	(802)
Other 	(1) 	8 	350 	330 	- 	687
Value of in-force business at 31 December 2024 	27 821 	39 799 	15 474 	14 403 	- 	97 497
Shareholders’ funds per Balance Sheet 	4 474 	34 211 	9 992 	4 313 	11 654 	64 644
Adjustment to shareholders' funds 	- 	(23 982) 	(4 673) 	(11 187) 	(2 683) 	(42 525)
Embedded value at 31 December 2024 	32 295 	50 028 	20 793 	7 529 	8 971 	119 616
5 EV Buildup per Entity

-- 5 of 18 --

COMPONENTS OF ASSETS UNDER INSURANCE CONTRACTS AND ADJUSTMENT TO
SHAREHOLDERS' FUNDS ON PUBLISHED BASIS
R million 	December 2024
1. Assets under insurance contracts
Discovery Life positive liabilities not netted off with negative liabilities: 	628
Discovery Life long term reserves in respect of policies with net negative liabilities: 	(35 813)
Working capital 	226
Discovery Life liability for incurred claims (LIC) 	7 731
Total Assets under insurance contracts: 	(27 228)
0
2. Negative liabilites not included under assets under insurance contracts
Negative reserve in respect of Invest business 	(7 351)
DAC and DRL in respect of Invest business 	(773)
(8 124)
-
3. Components to be zeroised based on the Method of Distributable Cashflows: 	-
Discovery Life long term reserves in respect of policies with net negative liabilities: 	(35 813)
Liabilities under reinsurance contracts* 	462
Negative reserve in respect of Invest business 	(7 351)
DAC and DRL in respect of Invest business 	(773)
Adjust for reduction on Deferred Tax Liability as a result of reduction in earnings 	7 678
Liabilities off set against Negative reserve before zeroisation 	11 815
(23 982)
* This amount is the liability under reinsurance contracts, net of CSM, in respect of the portion of the gross assets under insurance contracts zeroised based on the
method of distributable cashflows.
4. Other adjustments to published Shareholders' funds
VitalityLife net assets under insurance contracts 	(11 179)
VitalityHealth Insurance Acquisition Cash Flow (IACF) asset 	(4 673)
VitalityLife receivable relating to the Unemployment Cover benefit (net of deferred tax) 	(8)
Goodwill 	(2 922)
Intangible assets (net of deferred tax) relating to the acquisition of Standard Life Healthcare and the Prudential Assurance
Company joint venture (807)
Net preference share capital 	(779)
Reversal of 1 Discovery Place IFRS 16 financial lease accounting 	1 516
Equity settled share based payment mark-to-market adjustment 	309
Adjustment to Shareholders' funds from published basis 	(42 525)
6 EV Adjustment to SH funds

-- 6 of 18 --

RECONCILIATION TO THE REQUIRED CAPITAL
for the year ended 31 December 2024
R million Health and Vitality Life and Invest VitalityHealth 	VitalityLife 	Total
Opening - 30 June 2024 	1 238 	27 935 	4 138 	11 299 	44 610
- Methodology and Basis Changes 	- 	1 050 	- 	(110) 	940
- Expected release on in-force at start of period 	(56) 	(446) 	(74) 	(349) 	(925)
- Impact of new business written 	87 	445 	223 	1 061 	1 816
- Other changes* 	11 	1 301 	(28) 	16 	1 300
- Exchange rate movements 	- 	89 	276 	365
Change in Required Capital 	42 	2 350 	210 	894 	3 496
Closing - 31 December 2024 	1 280 	30 285 	4 348 	12 193 	48 106
*This line includes, amongst other things, the impact of rebasing the yield curve as part of the opening to closing reconciliation of required
capital. This component of the expected yield curve unwind is shown separately from the expected release for information purposes only.
7 Recon of Required Capital

-- 7 of 18 --

BREAKDOWN OF INVEST ASSETS UNDER ADMINISTRATION
R million 	Total
December 2021 	127 632
June 2022 	121 737
December 2022 	130 830
June 2023 	140 378
December 2023 	144 810
June 2024 	154 653
December 2024 	166 915
8 Invest AUA

-- 8 of 18 --

SA 	SA 	SA 	SA 	SA 	UK 	UK 	ALL OTHER SEGMENT 	IFRS
R million 	HEALTH 	LIFE 	INVEST 	INSURE 	BANK 	HEALTH 	LIFE 	SEGMENTS TOTAL 	TOTAL
31 December 2024
Income statement
Insurance revenue 	236 	9 286 	2 209 	3 078 	- 	9 112 	3 758 	95 	27 774 	- 	27 774
- Contracts measured under the General measurement model/Variable fee approach 	- 	7 437 	2 209 	- 	- 	- 	3 758 	- 	13 404 	- 	13 404
- Contracts measured under Premium allocation approach 	236 	1 849 	- 	3 078 	- 	9 112 	- 	95 	14 370 	- 	14 370
Insurance service expenses 	( 146) 	(7 837) 	(1 327) 	(2 690) 	- 	(8 280) 	(3 290) 	( 111) 	(23 681) 	- 	(23 681)
- Claims and benefits 	( 94) 	(5 788) 	( 295) 	(1 568) 	- 	(5 367) 	(1 693) 	( 74) 	(14 879) 	- 	(14 879)
- Insurance service expense and other 	( 27) 	( 990) 	( 522) 	( 672) 	- 	(1 957) 	( 173) 	( 33) 	(4 374) 	- 	(4 374)
- Insurance acquisition cash flows 	( 25) 	(1 059) 	( 510) 	( 450) 	- 	( 956) 	(1 424) 	( 4) 	(4 428) 	- 	(4 428)
Insurance service result (pre-reinsurance) 	90 	1 449 	882 	388 	- 	832 	468 	( 16) 	4 093 	- 	4 093
Net income/(expenses) from reinsurance contracts 	( 1) 	( 530) 	- 	( 52) 	- 	- 	( 239) 	6 	( 816) 	- 	( 816)
- Reinsurance expense 	( 1) 	(1 876) 	- 	( 66) 	- 	( 2) 	(4 270) 	( 33) 	(6 248) 	- 	(6 248)
- Insurance claims recovered from reinsurers 	- 	1 346 	- 	14 	- 	2 	4 031 	39 	5 432 	- 	5 432
Insurance service result 	89 	919 	882 	336 	- 	832 	229 	( 10) 	3 277 	- 	3 277
Net financial result from insurance finance income and expense 	- 	1 350 	(7 454) 	- 	- 	- 	145 	- 	(5 959) 	( 47) 	(6 006)
- Net finance income/(expense) from insurance contracts 	- 	1 421 	(7 454) 	- 	- 	- 	273 	- 	(5 760) 	( 47) 	(5 807)
- Net finance income/(expense) from reinsurance contracts 	- 	( 71) 	- 	- 	- 	- 	( 128) 	- 	( 199) 	- 	( 199)
Investment income using the effective interest rate method 	9 	2 	42 	123 	- 	51 	44 	8 	279 	182 	461
Net fair value (losses)/gains on financial instruments at fair value through profit or loss 	6 	267 	8 216 	8 	( 1) 	60 	- 	1 317 	9 873 	2 764 	12 637
Fair value adjustments to liabilities under investment contracts 	- 	- 	( 602) 	- 	- 	- 	- 	(1 317) 	(1 919) 	- 	(1 919)
Third-party interest: fair value adjustments to liabilities under investment contracts 	- 	- 	- 	- 	- 	- 	- 	- 	- 	(2 401) 	(2 401)
Intersegment funding 	- 	237 	( 237) 	- 	- 	- 	- 	- 	- 	- 	-
Other gains/(losses) on financial instruments 	- 	- 	- 	- 	( 9) 	- 	- 	- 	( 9) 	- 	( 9)
Net insurance and investment results 	104 	2 775 	847 	467 	( 10) 	943 	418 	( 2) 	5 542 	498 	6 040
Fee income from administration businesses 	4 744 	- 	989 	- 	- 	17 	- 	1 630 	7 380 	( 66) 	7 314
Vitality income 	- 	- 	- 	- 	- 	16 	128 	2 741 	2 885 	( 267) 	2 618
Net banking fee and commission income 	- 	- 	- 	- 	611 	- 	- 	( 30) 	581 	150 	731
- Banking fee and commission income 	- 	- 	- 	- 	1 036 	- 	- 	- 	1 036 	- 	1 036
- Banking fee and commission expense 	- 	- 	- 	- 	( 425) 	- 	- 	( 30) 	( 455) 	150 	( 305)
Net banking interest and similar income 	- 	- 	- 	- 	489 	- 	- 	- 	489 	- 	489
- Banking interest and similar income using the effective interest rate 	- 	- 	- 	- 	1 105 	- 	- 	- 	1 105 	- 	1 105
- Banking interest and similar expense using the effective interest rate 	- 	- 	- 	- 	( 616) 	- 	- 	- 	( 616) 	- 	( 616)
Other income 	882 	61 	- 	16 	21 	10 	- 	7 161 	8 151 	(7 215) 	936
Non-insurance revenue and income 	5 626 	61 	989 	16 	1 121 	43 	128 	11 502 	19 486 	(7 398) 	12 088
Net income 	5 730 	2 836 	1 836 	483 	1 111 	986 	546 	11 500 	25 028 	(6 900) 	18 128
Non-insurance acquisition costs 	- 	- 	( 486) 	- 	- 	- 	- 	( 114) 	( 600) 	- 	( 600)
Expected credit losses 	- 	- 	- 	- 	( 118) 	- 	- 	- 	( 118) 	- 	( 118)
Marketing and administration expenses 	(3 707) 	( 224) 	( 446) 	( 118) 	(1 138) 	( 387) 	( 221) 	(11 473) 	(17 714) 	7 181 	(10 533)
Share of net profits from equity-accounted investments 	- 	- 	- 	36 	- 	- 	2 	386 	424 	( 25) 	399
Normalised profit/(loss) from operations 	2 023 	2 612 	904 	401 	( 145) 	599 	327 	299 	7 020 	256 	7 276
Investment income earned on shareholder investments and cash 	43 	14 	5 	- 	- 	- 	- 	120 	182 	( 182) 	-
Intercompany investment income 	- 	- 	- 	- 	- 	- 	- 	681 	681 	( 681) 	-
Net fair value (losses)/gains on financial assets at fair value through profit or loss 	- 	41 	35 	- 	- 	- 	- 	2 	78 	( 78) 	-
Gain/(Loss) from dilution of equity accounted investments 	- 	- 	- 	( 26) 	- 	- 	- 	- 	( 26) 	- 	( 26)
Gain/(Loss) as a result of obtaining or losing control of previously held interest 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
Impairment of goodwill 	- 	- 	- 	- 	- 	- 	- 	- 	- 	- 	-
Amortisation of intangibles from business combinations 	- 	- 	- 	( 25) 	- 	- 	- 	( 29) 	( 54) 	54 	-
Market rentals related to Head Office building adjusted for finance costs and depreciation 	- 	- 	- 	- 	- 	- 	- 	( 44) 	( 44) 	44 	-
Restructuring costs 	- 	- 	- 	- 	- 	- 	- 	( 46) 	( 46) 	46 	-
Interest expenses on borrowings and lease liabilities 	( 1) 	- 	- 	- 	- 	( 10) 	( 104) 	( 839) 	( 954) 	( 140) 	(1 094)
Intercompany finance expenses on borrowings 	( 222) 	- 	- 	- 	- 	- 	( 225) 	( 234) 	( 681) 	681 	-
Foreign exchange gains/(losses) 	( 2) 	3 	( 6) 	- 	- 	- 	- 	18 	13 	- 	13
Profit/(loss) before income tax 	1 841 	2 670 	938 	350 	( 145) 	589 	( 2) 	( 72) 	6 169 	- 	6 169
Income tax expense 	( 497) 	( 715) 	( 401) 	( 101) 	32 	( 147) 	( 31) 	20 	(1 840) 	- 	(1 840)
Profit/(loss) for the period 	1 344 	1 955 	537 	249 	( 113) 	442 	( 33) 	( 52) 	4 329 	- 	4 329
Profit attributable to:
- Ordinary shareholders 	1 347 	1 955 	537 	249 	( 113) 	442 	( 33) 	( 99) 	4 285 	- 	4 285
- Preference shareholders 	- 	- 	- 	- 	- 	- 	- 	47 	47 	- 	47
- Non-controlling interest 	( 3) 	- 	- 	- 	- 	- 	- 	- 	( 3) 	- 	( 3)
Segment information
IFRS
REPORTING
ADJUSTMEN

-- 9 of 18 --

VIF, APE AND VNB SPLIT BETWEEN LIFE AND INVEST
R million 	December 2024 June 2024 December 2023 	June 2023 December 2022 	June 2022
VIF1
Life 	27 082 	24 138 	22 859 	22 244 	23 133 	22 059
Invest 	12 715 	11 675 	10 429 	9 393 	9 521 	8 505
APE2
Life 	355 	804 	426 	823 	463 	837
Invest 	1 234 	2 411 	1 150 	2 142 	1 033 	2 158
VNB1
Life 	94 	225 	136 	162 	169 	364
Invest 	145 	256 	106 	267 	160 	341
1 These VIF and VNB numbers are after allowing for the Cost of required Capital.
2 APE is the Annual Premium Income (or Annual Premium Equivalent in the case of Single Premium Investment business) in relation to New Business
only, and excludes any addition to Existing Business premiums arising from servicing increases and ACIs.
Discovery Retirement Optimiser (DRO) product moved from Life to Invest in line with disclosures for December 2016 and later periods.
10 Results split Life and Invest

-- 10 of 18 --

Group Shareholder Free Cash Movement
R millions 	H1 FY2025 	FY2024 	H1 FY2024 	FY2023
Cash Generated from In-Force Before Financing and Tax 	8 319 	14 617 	7 567 	14 425
New Business Net of External Financing 	(3 506) 	(6 823) 	(3 528) 	(7 243)
Tax Paid 	(758) 	(1 522) 	(792) 	(1 839)
Operating Cash Flow 	4 055 	6 272 	3 247 	5 343
New Initiatives 	(727) 	(1 025) 	(776) 	(1 671)
Business Development and Other 	(594) 	(1 580) 	(864) 	(1 274)
Finance Cost Paid 	(899) 	(1 566) 	(802) 	(1 501)
Dividends Paid 	(1 073) 	(1 270) 	(783) 	(69)
Financing and Matching Initiatives 	(236) 	(496) 	(332) 	166
Transactions with Borrowers (Excl. Finance Costs) 	(491) 	1 130 	(80) 	(597)
Movement in Shareholder Free Cash 	35 	1 465 	(390) 	397
Remove ordinary dividends paid in period 	1 028 	1 179 	740 	-
Add ordinary dividends payable in respect of period 	(591) 	(1 467) 	(439) 	(740)
Movement in Shareholder Free Cash – Dividend Accrual Basis (1) 	437 	1 177 	(89) 	(343)
Operating Cash Flow 	4 055 	6 272 	3 247 	5 343
IFRS Normalised Operating Profit net of Tax Expense 	5 436 	9 465 	4 343 	8 356
Cash Conversion Ratio 	75% 	66% 	75% 	64%
The cash conversion ratio is calculated as Operating Cash Flow per the Group shareholder free cash movement, divided by Normalised profit from operations (IFRS total)
net of Income tax expense (IFRS total) per A.1 Segment Information.
Restatement of Operating Cash Flow
The following table indicates the portion of "Operating Cash Flow" representing the net external FinRe cash flows for VitalityLife, previously disclosed
in "Financing and Matching Activities":
R millions 	H1 FY2025 	FY2024 	H1 FY2024 	FY2023
Operating Cash Flow - Before Net New Business Funding (Repayments and Funding) 	3 332 	5 322 	2 902 	5 337
Net New Business Funding (Repayments and Funding) 	723 	950 	345 	6
Operating Cash Flow 	4 055 	6 272 	3 247 	5 343
Group Shareholder Free Cash Movement - Reconciliation to Profit for the Period
R millions 	H1 FY2025 	FY2024 H1 FY2024 (2) 	FY2023 (2)
Profit for the period 	4 329 	7 364 	3 278 	6 572
Reverse non-cash profit items:
Share of net (profits)/losses from equity accounted investments 	(425) 	(1 031) 	(302) 	(561)
Losses/(gains) from dilution of equity accounted investments 	26 	(22) 	- 	5
Depreciation and amortisation 	1 074 	2 160 	1 040 	1 972
Impairment of intangible assets 	21 	45 	4 	61
Deferred acquisition costs (Excl. Invest DAC and exchange rate movements) 	- 	- 	- 	(42)
Movement in contract assets 	(462) 	(640) 	(252) 	52
Amortisation of intangibles from business combinations 	- 	- 	- 	56
Non cash impact of Vitality Health DAC 	(217) 	(411) 	(206) 	(753)
Non-cash fair value gains on financial assets 	(47) 	(87) 	(56) 	(214)
Non-cash forex gains / losses 	- 	- 	- 	9
Bank interest income incurred to cash 	(277) 	- 	- 	-
Other non-cash adjustments to profit 	(327) 	(152) 	(64) 	(178)
Adjustments from IFRS to EV ANW:
Increase in Negative Reserves and Invest DAC (Net of tax) 	(1 487) 	(4 547) 	(1 702) 	(5 393)
Exchange rate movements on Vitality Life Negative Reserves 	206 	(385) 	(137) 	1 900
Other adjustments to arrive at EV ANW 	404 	1 644 	137 	196
Incurred to Cash basis:
- Rent Paid 	(329) 	(511) 	(286) 	(328)
- Finance Costs Paid 	(1 494) 	(2 603) 	(802) 	(1 501)
- Finance Costs Accrued 	1 711 	3 097 	1 025 	1 941
- Taxation paid 	(758) 	(1 522) 	(792) 	(1 839)
- Taxation Accrued 	654 	1 093 	810 	1 495
Investing Activities:
Purchase of property and equipment 	(120) 	(414) 	(246) 	(551)
Proceeds from disposal of property and equipment 	3 	28 	- 	2
Purchase of intangible assets 	(875) 	(1 789) 	(800) 	(1 760)
Increase in investment in associate 	294 	287 	(176) 	(75)
Acquisition of business net of cash required 	(304) 	- 	- 	(3)
Cash proceeds from CMT transaction 	- 	- 	- 	-
Financing Activities:
Increase in borrowings 	1 765 	2 005 	500 	7 441
Repayment of borrowings 	(2 257) 	(874) 	(580) 	(8 038)
Dividends paid to ordinary shareholders 	(1 026) 	(1 179) 	(739) 	-
Dividends paid to preference shareholders 	(47) 	(91) 	(44) 	(69)
Movement in Shareholder Free Cash 	35 	1 465 	(390) 	397
Notes
From FY2024, and restated for prior periods, the net external FinRe cash flows for VitalityLife (relating to the partial funding of new business acquisition costs) have been reallocated to
“Operating Cash Flow”, with FinRe repayments included in "Cash Generated from In-Force Before Financing and Tax" and new FinRe receivables offset against "New Business Net of
External Financing". Previously, the net external FinRe cash flows for VitalityLife were included in “Financing and Matching Activities”.
Vitality Life utilises FinRe to manage the upfront acquisition costs of writing new business. To the degree that FinRe is raised specifically for the purpose of writing new business,
management believes offsetting this funding against new business acquisition costs is a more informative representation of operational cash flow, which has led to this enhancement. The
increased use of FinRe in the reporting period follows the significant increase in new business volumes in VitalityLife from FY2024, represented in "New Business Net of External Financing"
in the Movement in Shareholder Free Cash.
"Movement in Shareholder Free Cash" is an estimate of shareholder free cashflow. Life and Invest and VitalityLife are included based on the change in the Adjusted Net Worth in the Embedded Value. Changes in working
capital are not allowed for in the estimate.
1) This view of the movement in shareholder free cash flow aligns the dividend paid to the period against which the cash flow was generated to fund it. For 31 December 2024, the declared dividend of R591m, per the
interim financial results, is used as the dividend accrued in respect of the six month period.
2) "Profit for the period" for H1 FY2024 and FY2023 has been restated as a result of prior period errors - refer to D.1.1 for more detail. The restatements do not affect the net Movement in Shareholder Free Cash Flow for
those periods as they relate to movements in Vitality Life Limited's net assets under insurance contracts, which are non-cash flow movements. The offsetting adjustment has been included in "Increase in Negative Reserves
and Invest DAC (Net of tax)" in the build-up above.

-- 11 of 18 --

Reconciliation of operating profit to normalised operating profit
for the six months ended 31 December 2024
Group Group
R million
Half-year
ended
December
2024
Half-year
ended
December
2023
change
Operating profit 	6 877 	5 466 	26%
Share of net profits from equity accounted investments 	399 	278
Normalised profit from operations per Segment information (IFRS total) 	7 276 	5 744 	27%
Normalised profit adjustments 	( 256) 	( 208)
Investment income earned on shareholder investments and cash 	( 182) 	( 139)
Difference between market related rental and depreciation and finance costs (Head office) 	( 96) 	( 85)
Net fair value gains on financial assets at fair value through profit or loss 	( 78) 	( 56)
Amortisation of intangibles from business combinations 	54 	52
Restructuring costs 	46 	20
Normalised profit from operations 	7 020 	5 536 	27%
12 Op Profit recon

-- 12 of 18 --

Discovery Bank additional perforamance metrics
for the six months ended 31 December 2024
2025 H1 2024 H2 2024 H1 2023 H2 2023 H1
Profitability and Efficiency
Net Interest Margin (NIM) 	10.08% 10.11% 9.84% 9.50% 9.07%
Asset Quality
Non-Performing Loan (NPL) Ratio 	5.48% 5.84% 4.16% 7.44% 4.67%
Capital Adequacy
Common Equity Tier 1 (CET1) Ratio 16.67% 17.63% 17.07% 16.82% 16.47%
Liquidity
Loan-to-Deposit Ratio (LDR) 	37.05% 35.72% 34.48% 36.08% 23.46%

-- 13 of 18 --

NAV PER ENTITY
for the year ended June 2024
Covered businesses 	December 2024
NAV before adjustment to shareholder funds
Health and Vitality 	4 474
Life and Invest 	34 211
VitalityHealth 	9 992
VitalityLife 	4 313
Non-covered business
Bank, including DCS intangible asset and goodwill 	8 004
Insure 	2 369
PAHI 	7 230
CMT 	1 402
Limited 	(11 680)
Other 	4 329
Total NAV 	64 644

-- 14 of 18 --



-- 15 of 18 --

PAHI performance metrics
RMB million 	December 2024 December 2023 %change 2024 	2023 	%change
New business PAHI total (100%) 	2 088 	1 764 	18% 	4 698 	4 027 	17%
New business PAHI Own Licence 	1 743 	1 591 	10% 	3 994 	3 721 	7%
New business PAHI Reinsurance 	345 	173 	99% 	704 	306 	130%
New business PAHI total (25%) 	522 	441 	18% 	1 174 	1 007 	17%
New business PAHI Own Licence 	435 	398 	10% 	998 	930 	7%
New business PAHI Reinsurance 	86 	43 	99% 	176 	77 	130%
Total written premium (100%) 	10 998 	9 014 	22% 	24 629 	20 440 	20%
Written premium-own licence 	7 452 	6 535 	14% 	17 036 	15 250 	12%
Written premium-reinsurance 	3 545 	2 479 	43% 	7 593 	5 190 	46%
Earned premium (100%) 	8 729 	7 524 	16% 	16 525 	14 809 	12%
Own License 	8 286 	7 130 	16% 	15 904 	14 057 	13%
Reinsurance 	443 	395 	12% 	621 	752 	-17%
PAHI profit before investment income and gains (100%) 	306 	356 	-14% 	1 420 	1 122 	27%
PAHI investment income and gains (100%) 	599 	202 	196% 	1 018 	518 	97%
PAHI pre-tax profit (100%) 	906 	559 	62% 	2 439 	1 640 	49%
PAHI profit before income and gains (25%) 	226 	140 	62% 	609 	410 	49%
Investible assets 	24 338 	21 571 	13% 	24 338 	21 571 	13%
Full years (calendar year)	Half-years (DSY reporting cycle)
Note: PAHI reinsurance information has been provided as additional information. Going forward, only direct own license information will be
provided, which aligns the respective metric with the economics of the business

-- 16 of 18 --



-- 17 of 18 --

Normalised Return on Equity
H1 FY2025 FY2024 H1 FY2024 FY2023
EARNINGS
Net profit - attributable to: 	4 329 	7 364 	3 278
- Ordinary shareholders 	4 285 	7 283 	3 239 	A
- Preference shareholders 	47 	91 	44
- Non-controlling interest 	(3) 	(10) 	(5)
Earnings adjustments for ordinary shareholders 	65 	46 	17 	C=B-A
Normalised headline earnings 	4 350 	7 329 	3 256 	B
EQUITY
Opening total equity 	57 719 	49 724 	49 724
- Insurance Finance Reserve 	(733) 	(3 184) 	(3 184)
- Perpetual preference share capital 	779 	779 	779
- Non-controlling interest 	- 	4 	4
- Other equity 	57 673 	52 125 	52 125 	D
Adjusted opening equity 	57 673 	52 125 	52 125 	E=D
Closing total equity 	64 644 	57 719 	53 140 	49 724
- Insurance Finance Reserve 	1 761 	(733) 	(2 144) 	(3 184)
- Perpetual preference share capital 	779 	779 	779 	779
- Non-controlling interest 	(3) 	- 	4 	4
- Other equity 	62 107 	57 673 	54 501 	52 125 	F
Adjusted closing equity 	62 107 	57 673 	54 501 	52 125 	G=F
Normalised adjusted closing equity 	62 172 	57 719 	54 518 	52 125 	H=G+C
Average normalised equity 	59 923 	54 922 	53 322 	I=(H+E)/2
RETURN ON EQUITY 	Full-year Half-year
Normalised return on equity (annualised) 	15.0% 	13.3% 	12.6% 	=B/I =(1+B/I)^2-1

-- 18 of 18 --